| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $31.86M | $22.70M | $17.78M | $7.09M | $3.81M |
| SG&A | $7.85M | $7.22M | $7.29M | $7.79M | $3.63M |
| Operating Income | -$39.70M | -$29.92M | -$25.07M | -$15.38M | -$10.53M |
| Interest Expense | – | – | – | – | $64.24K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$36.12M | -$26.73M | -$23.96M | -$14.84M | -$10.46M |
| EPS (basic) | -0.3800 | -0.4600 | -1.5000 | -0.9300 | -3.6900 |
| EPS (diluted) | -0.3800 | -0.4600 | -1.5000 | -0.9300 | -3.6900 |
| Shares (diluted) | $95.19M | $58.42M | $15.97M | $15.97M | $2.83M |